Literature DB >> 3378625

Phospholipid uptake by Plasmodium knowlesi infected erythrocytes.

G N Moll1, H J Vial, M L Ancelin, J A Op den Kamp, B Roelofsen, L L van Deenen.   

Abstract

The uptake of phosphatidylcholine (PC), phosphatidylethanolamine (PE) and phosphatidylserine (PS) in Plasmodium knowlesi infected erythrocytes has been studied. Whereas uptake of phospholipids, in the absence of phospholipid transfer proteins, is negligible in control cells, the infected cells can incorporate considerable amounts of added phospholipids. The uptake is enhanced by the presence of lipid transfer proteins. Doubly labeled [3H]oleate, [14C]choline) PC does not undergo any appreciable remodelling following uptake, which strongly suggests that plasma PC is used as such for the biogenesis of the parasite membranes. Transport of extracellularly offered PS and PE towards the intraerythrocytic parasite and utilization of these lipids by the parasite are confirmed by the observation that these lipids are converted into respectively PE and PC. The extent and rate of these conversions depend on the way the phospholipids are introduced into the infected cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3378625     DOI: 10.1016/0014-5793(88)80765-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Rodent and nonrodent malaria parasites differ in their phospholipid metabolic pathways.

Authors:  Sandrine Déchamps; Marjorie Maynadier; Sharon Wein; Laila Gannoun-Zaki; Eric Maréchal; Henri J Vial
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

2.  Metabolome-wide association study of peripheral parasitemia in Plasmodium vivax malaria.

Authors:  Luiz Gustavo Gardinassi; Regina Joice Cordy; Marcus V G Lacerda; Jorge L Salinas; Wuelton M Monteiro; Gisely C Melo; André M Siqueira; Fernando F Val; ViLinh Tran; Dean P Jones; Mary R Galinski; Shuzhao Li
Journal:  Int J Med Microbiol       Date:  2017-09-06       Impact factor: 3.473

3.  Modification of host cell membrane lipid composition by the intra-erythrocytic human malaria parasite Plasmodium falciparum.

Authors:  L L Hsiao; R J Howard; M Aikawa; T F Taraschi
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

4.  Targeting the Lipid Metabolic Pathways for the Treatment of Malaria.

Authors:  Choukri Ben Mamoun; Sean T Prigge; Henri Vial
Journal:  Drug Dev Res       Date:  2010-02       Impact factor: 4.360

5.  Recent insights into fatty acid acquisition and metabolism in malarial parasites.

Authors:  Bamini Jayabalasingham; Robert Menard; David A Fidock
Journal:  F1000 Biol Rep       Date:  2010-03-25

6.  Kinetic modelling of phospholipid synthesis in Plasmodium knowlesi unravels crucial steps and relative importance of multiple pathways.

Authors:  Partho Sen; Henri J Vial; Ovidiu Radulescu
Journal:  BMC Syst Biol       Date:  2013-11-09

7.  Oleic acid biosynthesis in Plasmodium falciparum: characterization of the stearoyl-CoA desaturase and investigation as a potential therapeutic target.

Authors:  Paul Gratraud; Enlli Huws; Brie Falkard; Sophie Adjalley; David A Fidock; Laurence Berry; William R Jacobs; Mark S Baird; Henri Vial; Laurent Kremer
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

8.  Modulation of Lipoprotein Cholesterol Levels in Plasmodium berghei Malarial Infection by Crude Aqueous Extract of Ganoderma lucidum.

Authors:  Olarewaju M Oluba; Augustine O Olusola; George O Eidangbe; Leye J Babatola; E Chukwu Onyeneke
Journal:  Cholesterol       Date:  2012-07-25

9.  Transport of fluorescent phospholipid analogues from the erythrocyte membrane to the parasite in Plasmodium falciparum-infected cells.

Authors:  K Haldar; A F de Amorim; G A Cross
Journal:  J Cell Biol       Date:  1989-06       Impact factor: 10.539

10.  Lipid traffic between high density lipoproteins and Plasmodium falciparum-infected red blood cells.

Authors:  P Grellier; D Rigomier; V Clavey; J C Fruchart; J Schrevel
Journal:  J Cell Biol       Date:  1991-01       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.